Armistice Capital »

Global Payments shares owned by Armistice Capital

Quarter-by-quarter ownership of Global Payments (GPN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Global Payments

Tip: Access up to 7 years of quarterly data

All positions including Global Payments held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global Payments by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $215k 3.0k 72.56
2021-09-30 $10M 65k 157.58

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Global Payments

GTCR
BlackRock
Vanguard Capital Management
Harris Associates L.P
Ameriprise Financial
Pzena Investment Management
State Street Corporation
Vanguard Portfolio Management
Glenview Captal Management
Bank of America Corporation
FMR
Pinnacle Financial Partners
Geode Capital Management
Invesco
UBS Group

View all funds holding Global Payments